206 related articles for article (PubMed ID: 9882797)
21. Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms.
Gacchina CE; Deb P; Barth JL; Ramamurthi A
Tissue Eng Part A; 2011 Jul; 17(13-14):1699-711. PubMed ID: 21341992
[TBL] [Abstract][Full Text] [Related]
22. Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms.
Sho E; Chu J; Sho M; Fernandes B; Judd D; Ganesan P; Kimura H; Dalman RL
J Vasc Surg; 2004 Jun; 39(6):1312-21. PubMed ID: 15192574
[TBL] [Abstract][Full Text] [Related]
23. Serum Calprotectin as a Novel Biomarker in Abdominal Aortic Aneurysm Pathogenesis and Progression: Preliminary Data from Experimental Model in Rats.
Moris D; Theocharis S; Davakis S; Patelis N; Agrogiannis G; Vlachos IS; Spartalis E; Athanasiou A; Bakoyiannis C; Perrea DN; Georgopoulos S
Curr Vasc Pharmacol; 2018 Jan; 16(2):168-178. PubMed ID: 28155626
[TBL] [Abstract][Full Text] [Related]
24. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms.
Elmore JR; Keister BF; Franklin DP; Youkey JR; Carey DJ
Ann Vasc Surg; 1998 May; 12(3):221-8. PubMed ID: 9588507
[TBL] [Abstract][Full Text] [Related]
25. Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.
Morimoto K; Hasegawa T; Tanaka A; Wulan B; Yu J; Morimoto N; Okita Y; Okada K
J Vasc Surg; 2012 Jun; 55(6):1749-58. PubMed ID: 22341578
[TBL] [Abstract][Full Text] [Related]
26. In vivo evaluation of a new magnetic resonance imaging contrast agent (P947) to target matrix metalloproteinases in expanding experimental abdominal aortic aneurysms.
Bazeli R; Coutard M; Duport BD; Lancelot E; Corot C; Laissy JP; Letourneur D; Michel JB; Serfaty JM
Invest Radiol; 2010 Oct; 45(10):662-8. PubMed ID: 20733508
[TBL] [Abstract][Full Text] [Related]
27. Influence of the matrix metalloproteinase inhibitor batimastat (BB-94) on periodontal bone destruction in Sprague-Dawley rats.
Björnsson MJ; Havemose-Poulsen A; Stoltze K; Holmstrup P
J Periodontal Res; 2004 Aug; 39(4):269-74. PubMed ID: 15206921
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 beta induces differential gene expression in aortic smooth muscle cells.
Keen RR; Nolan KD; Cipollone M; Scott E; Shively VP; Yao JS; Pearce WH
J Vasc Surg; 1994 Nov; 20(5):774-84; discussion 784-6. PubMed ID: 7966813
[TBL] [Abstract][Full Text] [Related]
29. Elastin stabilization for treatment of abdominal aortic aneurysms.
Isenburg JC; Simionescu DT; Starcher BC; Vyavahare NR
Circulation; 2007 Apr; 115(13):1729-37. PubMed ID: 17372168
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of matrix metalloproteinases reduces local and distant organ injury following experimental acute pancreatitis.
Muhs BE; Patel S; Yee H; Marcus S; Shamamian P
J Surg Res; 2003 Feb; 109(2):110-7. PubMed ID: 12643851
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta.
Palombo D; Maione M; Cifiello BI; Udini M; Maggio D; Lupo M
J Cardiovasc Surg (Torino); 1999 Apr; 40(2):257-60. PubMed ID: 10350113
[TBL] [Abstract][Full Text] [Related]
32. Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits.
Mastoraki ST; Toumpoulis IK; Anagnostopoulos CE; Tiniakos D; Papalois A; Chamogeorgakis TP; Angouras DC; Rokkas CK
Ann Vasc Surg; 2012 Feb; 26(2):250-8. PubMed ID: 22222170
[TBL] [Abstract][Full Text] [Related]
33. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
[TBL] [Abstract][Full Text] [Related]
34. Elastase is not sufficient to induce experimental abdominal aortic aneurysms.
Carsten CG; Calton WC; Johanning JM; Armstrong PJ; Franklin DP; Carey DJ; Elmore JR
J Vasc Surg; 2001 Jun; 33(6):1255-62. PubMed ID: 11389426
[TBL] [Abstract][Full Text] [Related]
35. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer.
Wojtowicz-Praga S; Low J; Marshall J; Ness E; Dickson R; Barter J; Sale M; McCann P; Moore J; Cole A; Hawkins MJ
Invest New Drugs; 1996; 14(2):193-202. PubMed ID: 8913840
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.
Mucha SA; Meleń-Mucha G; Godlewski A; Stepień H
Virchows Arch; 2007 Mar; 450(3):335-41. PubMed ID: 17235567
[TBL] [Abstract][Full Text] [Related]
37. In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate.
Sheth RA; Maricevich M; Mahmood U
Atherosclerosis; 2010 Sep; 212(1):181-7. PubMed ID: 20542274
[TBL] [Abstract][Full Text] [Related]
38. Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors.
Armstrong PJ; Franklin DP; Carey DJ; Elmore JR
Ann Vasc Surg; 2005 Mar; 19(2):248-57. PubMed ID: 15770365
[TBL] [Abstract][Full Text] [Related]
39. The effect of tumor necrosis factor binding protein and interleukin-1 receptor antagonist on the development of abdominal aortic aneurysms in a rat model.
Hingorani A; Ascher E; Scheinman M; Yorkovich W; DePippo P; Ladoulis CT; Salles-Cunha S
J Vasc Surg; 1998 Sep; 28(3):522-6. PubMed ID: 9737463
[TBL] [Abstract][Full Text] [Related]
40. Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat.
Holmes DR; Petrinec D; Wester W; Thompson RW; Reilly JM
J Surg Res; 1996 Jun; 63(1):305-9. PubMed ID: 8661215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
